Clinical trials query results
From Health Canada
- Medical condition:
- PLEURAL MESOTHELIOMA
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- MK-3475 (PEMBROLIZUMAB)
- Protocol title:
- A PHASE II RANDOMIZED STUDY OF PEMBROLIZUMAB IN PATIENTS WITH ADVANCED MALIGNANT PLEURAL MESOTHELIOMA
- Sponsor name:
- CANADIAN CANCER TRIALS GROUP, CANCER RESEARCH INSTITUTE, QUEEN'S UNIVERSITY
- Date of no objection letter:
- 2016-05-20
- Control number:
- 194481
- Trial status:
- ONGOING
- Date study started:
- 2018-04-30